Trial Profile
A Prospective, Multisite, Observational Study Assessing Safety In Subjects From AR13324CS301 and AR13324CS302 Clinical Trials Who Developed Corneal Deposits
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Netarsudil (Primary)
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Adverse reactions
- 14 Jan 2020 Results published in the Internet Document
- 14 Jan 2020 New trial record